Data Extraction Table for "<i>Acne-Associated Post-Inflammatory Hyperpigmentation: A Systematic Review of Treatments and Guidelines for Clinicians</i>"

This data extraction table contains detailed information extracted from studies included in the systematic review titled "<i>Acne-Associated Post-Inflammatory Hyperpigmentation: A Systematic Review of Treatments and Guidelines for Clinicians.</i>" The table includes key study characteristics, patient characteristics, treatment information, and outcomes collected from relevant studies assessing treatments for Acne-Associated Post-Inflammatory Hyperpigmentation (AAPIH). <br><br>A systematic review was conducted in line with PRISMA guidelines and registered with PROSPERO (CRD420251041782). MEDLINE and Embase databases were searched for studies published between January 1999 and December 2024. Studies assessing treatments for AAPIH were selected based on predefined eligibility criteria using the PICOS framework. Levels of evidence were assessed, and a risk of bias analysis was conducted. Due to heterogeneity in treatment outcomes, a descriptive analysis was performed.<br><br>This table serves as a supplementary resource for the systematic review, providing comprehensive insight into the methodologies, patient demographics, treatment protocols, and clinical outcomes observed across the included studies.本数据提取表包含从题为《痤疮相关性炎症后色素沉着：面向临床医师的治疗与指南系统综述》（*Acne-Associated Post-Inflammatory Hyperpigmentation: A Systematic Review of Treatments and Guidelines for Clinicians.*）的系统综述所纳入的研究中提取的详细信息。本表涵盖了针对痤疮相关性炎症后色素沉着（Acne-Associated Post-Inflammatory Hyperpigmentation, AAPIH）的相关治疗评估研究中收集的核心研究特征、患者特征、治疗相关信息及研究结局数据。 本系统综述严格遵循PRISMA声明规范开展，并已在PROSPERO平台注册（编号：CRD420251041782）。研究团队检索了1999年1月至2024年12月期间发表于MEDLINE与Embase数据库的相关文献。研究纳入环节基于PICOS框架及预先设定的入选标准完成筛选。随后对研究的证据等级进行评估，并开展偏倚风险分析。鉴于各项研究的治疗结局存在异质性，最终采用描述性分析方法。 本表作为该系统综述的补充资源，全面呈现了纳入研究的研究方法、患者人口学特征、治疗方案及观测到的临床结局。